PHARMACOEPIDEMIOLOGICAL EVALUATION OF HIV PHARMACOTHERAPY AT DISTRICT ART CENTER IN SOUTH TELANGANA

Authors

  • SONALI B Department of Pharmacy Practice, Vikas College of Pharmaceutical Sciences, Suryapet, Telangana, India
  • AKHILA G Department of Pharmacy Practice, Vikas College of Pharmaceutical Sciences, Suryapet, Telangana, India
  • DIVYA R Department of Pharmacy Practice, Vikas College of Pharmaceutical Sciences, Suryapet, Telangana, India.
  • R ADEPU Department of Pharmacy Practice, Vikas College of Pharmaceutical Sciences, Suryapet, Telangana, India.
  • ANUSHA T Department of Pharmacy Practice, Vikas College of Pharmaceutical Sciences, Suryapet, Telangana, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i3.43907

Keywords:

Antiretroviral therapy, Prescription pattern, Adherence behavior, Pharmacoepidemiological survey

Abstract

Objective: Objective of the study was to assess the drug utilization pattern of antiretroviral drugs, and medication adherence behavior among human immunodeficiency virus (HIV) patients attending a local ART center, Suryapet, South Telangana.

Methods: This was a prospective observational study approved by institutional ethics committee. Demographic, clinical, laboratory, and the treatment details were collected on daily basis for new cases and the data add on was collected for old cases. Medication adherence behavior was assessed through Morisky Medication Adherence Scale-8.

Results: During the study period, a total of 505 HIV patients were enrolled. Among them, majority patients were women (61%), in the age group of 31–45 (49.7%). Illiterates (52.6%). Major mode of transmission identified was intimate contact (74%), and majority patients were in Stage I (49%). TLE regimen was prescribed in 69.9% patients and for children the prescribed regimen was ABC, 3TC, EFV (5.1%). About 43% patients were found with medium adherence.

Conclusion: This study concludes that the most prescribed regimens were combination of TLE, and majority of the patients were found with medium adherence.

Downloads

Download data is not yet available.

References

World Health Organization. A World Health Organization Resource, Introduction to Drug Utilization Research. Geneva: World Health Organization; 2003. Available from: http://apps.who.int/medicimedocs/ en/d/Js4876e/2.html

National AIDS Control Organization; 2018. Available from: http:// www.naco.gov.in

Jessica LA, Julie BD, Angela DM. Pharmacotherapy of HIV infection. In: Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, Kradjan WA, editors. Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs. 10th ed. Philadelphia, PA: Kluwer/Lippincott Williams and Wilkins; 2009. p. 1690-709.

Desai C, Dikshit R, Solanki M, Shah A, Kapadia J. A study of utilization pattern, efficacy and safety of drugs prescribed for opportunistic infections in human immunodeficiency virus infected patients. Int J Med Public Health 2014;4:200-9.

DiMatteo MR. Variations in patients’ adherence to medical recommendations; A quantitative review of 50 years of research. Med Care 2004;42:200-9.

Mira D, Geetha I, Dikshit RK. Antiretroviral drugs, critical issues and recent advances. Ind J Pharmacol 2012;44:288-98.

Joglekar N, Paranjape R, Jain R, Rahane G, Potdar R, Reddy KS, et al. Barriers to ART adherence and follow ups among patients attending Art Centres in Maharastra, India. Indian J Med Res 2011;134:954-9.

Mahathir M. Women at greater risk of HIV infection. Arrows Change 1997;3:1-2.

Valadares AL, Pinto-Neto AM, Abdo C, de Melo VH. HIV in middle aged women associated factors. Rev Assoc Med Bras (1992) 2010;56:112-5.

Stall R, Catania J. AIDS risk behaviours among late middle aged and elderly Americans. The National AIDS behavioural Surveys. JAMA 1994;154:57-63.

Gomez A. The gray hair revolution: Reflections and experiences on the aging of women. Latin American and Caribbean women’s health network. Cuad Mujer Salud 1999;4:2-8.

Chauhan NS, Shan SP, Shah A. A safety analysis of different drug regimen used in human immunodeficiency virus-positive patients. Indian J Sex Transm Dis AIDS 2018;39:84-90.

Patil PT, Pawar MP, Halasawadekar NR, Shinde MP, Kumbhar AV, Rathod MS. Current pattern of adverse drug reactions to antiretroviral therapy in an antiretroviral therapy centre attached to a government medical college of Maharastra, India: A retrospective study. Int J Basic Clin Pharmacol 2016;5:2438-43.

Sadiq S, Gupta S, Khajuria V, Tandon VR, Mahajan A, Gupta M. Adverse drug events due to antiretroviral therapy in a Northern Indian tertiary care institution. Natl J Physiol Pharm Pharmacol 2016;6:205-8.

Modi JP, Kubavat A, Mundhava S, Lalwani U. A prospective study to evaluate prescription pattern of second line antiretroviral therapy given to HIV patients. J Young Pharm 2018;10:117-22.

Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to antiretroviral therapy among people living with HIV. North Am J Med Sci 2013;5:220-3.

Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam JV. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res 2008;127:28-36.

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherance to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296:679-90.

Bezabhe WM, Peterson GM, Bereznicki L, Chalmers L, Gee P. Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: A study protocol. BMJ 2013;3:e003559.

Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV 1 infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002;360:119-29.

Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV infection. Ann Intern Med 1997;126:946-54.

Moore RD, Chaisson RE. National history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999;13:1933-42.

Lutwama F, Serwadda R, Mayanja-Kizza H, Shihab HM, Ronald A, Kamya MR, et al. Evaluation of Dynabeads and Cytosperes compared with flow cytometry to enumerate CD4+ T cells in HIV infected Ugandans on antiretroviral therapy. J Acquir Immune Defic Syndr 2008;48:297-303.

MacLennan CA, Liu MK, White SA, van Oosterhout JJ, Simukonda F, Bwanali J, et al. Diagnostic accuracy and clinical utility of a simplified low-cost method of counting CD4 cells with flow cytometry in Malawi: Diagnostic accuracy study. BMJ 2007;335:190.

Published

07-03-2022

How to Cite

B, S., A. . G, D. R, R ADEPU, and A. T. “PHARMACOEPIDEMIOLOGICAL EVALUATION OF HIV PHARMACOTHERAPY AT DISTRICT ART CENTER IN SOUTH TELANGANA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 3, Mar. 2022, pp. 56-59, doi:10.22159/ajpcr.2022.v15i3.43907.

Issue

Section

Original Article(s)